Precirix scores Series B
Precirix, a developer of precision radiopharmaceuticals in oncology, has raised 80 million euros in Series B financing.
Precirix, a developer of precision radiopharmaceuticals in oncology, has raised 80 million euros in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination